University of Dundee

Latest News for 05/2022

January 2022

  • 19 Jan 2022

    Review of the Year 2021 took place virtually today with the former Interim Dean, Inke Näthke sharing the highlights of activity within the School from 2021. Returning Dean, Julian Blow concluded the review with a look to the future where he highlighted plans for the coming year. The Review included the presentation of the annual School prizes. Here are the winners: People’s Award The People’s Award is for positive contributions to School culture.

  • 19 Jan 2022

    A parasitic infection that affects millions of people around the world is to be targeted by a £2.5 million drug discovery programme at the Universities of Dundee, Aberystwyth and Cardiff. Schistosomiasis, also known as Bilharzia, is a parasitic infection caused by tiny flatworms that live within the blood vessels around either the intestines or bladder. The infection is found in many tropical and sub-tropical regions of the world and is estimated to cause more than 230 million clinical cases every year.

  • Drug Discovery Unit Biology Lab
    17 Jan 2022

    Experts at the University’s Drug Discovery Unit (DDU) have been awarded a grant of $5 million over the next three years to support the Structure-guided Drug Discovery Coalition (SDDC). The consortium is working to identify lead compounds which can be used to develop advanced drug discovery programmes against malaria and tuberculosis.

May 2021

  • Professor Ian Gilbert
    12 May 2021

    The University of Dundee’s Professor Ian Gilbert has been elected to join the prestigious Fellowship of the Academy of Medical Sciences (AMS). Professor Gilbert is one of 50 prominent biomedical and health scientists to be elected to the respected and influential Fellowship.

April 2021

  • Mosquito (credit: Егор Камелев)
    28 Apr 2021

    Experts at the University of Dundee have been awarded £2.4 million to identify compounds that could pave the way for a single dose treatment for malaria. A team at the University’s Drug Discovery Unit (DDU), based within the School of Life Sciences, will utilise the funding to support development of a compound series that inhibits an enzyme involved in protein synthesis.

August 2020

  • Dr Susan Wyllie
    27 Aug 2020

    Scientists at the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee have been awarded £4.9million in follow-on funding from the Wellcome Trust, boosting their efforts to understand more about potential drugs that could be used to treat neglected tropical diseases (NTDs) and other parasitic diseases.

April 2020

  • DDD10749 - Malaria Compound
    28 Apr 2020

    Back in October 2013 Medicines for Malaria Venture (MMV) selected a compound designed and developed at the Drug Discovery Unit (DDU), University of Dundee to enter preclinical development. In June 2015, the discovery, properties and mode of action of the compound DDD107498 were published in the journal Nature.

March 2020

  • Professor Ian Gilbert and Professor Miratul Muqit
    03 Mar 2020

    Two Life Sciences academics who are helping transform lives with their work on major diseases including Parkinson’s and neglected tropical diseases such as malaria have been elected Fellows of the Royal Society of Edinburgh (RSE). The RSE is Scotland’s national academy, focused on delivering its mission of `knowledge made useful’. Fellows are elected in recognition of their impact in improving the world around them.

July 2019

  • left to right, Professor Kevin Grant, Dr Beatriz Baragaña and Professor Ian Gilbert, all of the Drug Discovery Unit
    11 Jul 2019

    Researchers from the Drug Discovery Unit have been awarded the “Project of the Year 2018” from Medicines for Malaria Venture (MMV) for their discovery work on potential new drugs for malaria. The annual award goes to the scientific partners involved in that year’s most exciting project from the MMV portfolio. MMV is the world’s leading product development partnership (PDP) for discovering and developing new effective and affordable medicines to treat malaria.

February 2019

  • 12 Feb 2019

    Researchers in the Wellcome Centre for Anti-Infectives Research (WCAIR) have been awarded £700,000 to investigate whether bacteria and other natural products found in the Amazon hold the key to developing new drugs for neglected tropical diseases. The team led by Professor Kevin Read will work with colleagues in Brazil to identify novel drug targets and develop new therapies for visceral leishmaniasis and Chagas’ disease.

Pages